Revance Therapeutics, Inc.: SCHEDULE 13G/A filed Feb 13, 2025

Form type

SCHEDULE 13G/A

Filing date

Feb 13, 2025

Accession number

0001306923-25-000009

Filer

Revance Therapeutics, Inc. (CIK 1479290)